[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"satisfaction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:satisfaction":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,23,0,[8,40,70,101,133,167,193,226,251,279,305,338,362,386,406,432,460,489,514,545,574,594,619],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100392456","inflatable-penile-prostheses--which-patients-can-correctly-use-the-scrotal-pump--100392456",false,"NCT04390230","Inflatable Penile Prostheses : Which Patients Can Correctly Use the Scrotal Pump ?","Inflatable Penile Prostheses : Predicting Factors of Pump Misuse and Unsatisfaction","All cases included were discussed and approved by a multidisciplinary team. Patients who underwent prosthesis replacement or second implantation were not included. We excluded patients who refused or were not able to answer our questionnaire, patients who provided unreliable answers, and patients that experimented a secondary malfunction of their IP.","MALE","18 Years",{"count":19,"type":20},120,"ESTIMATED","OBSERVATIONAL","Sexual health and satisfaction are well know as critical critera to assess quality of life, at any age. Among the multiple aspects of sexual health, erectile dysfunction (ED) is not anymore a fate, mainly thanks to the advent of phosphodiesterase type 5 (PDE5) inhibitors in 1998. Nevertheless, a significant part of patients are intolerant or does not respond to PDE5 inhibitors and thus are looking for other treatment options.\n\nSince the first implantation of foreign material intracarvernosally in 1966 by Beheri, multiple modifications and enhancements were achieved in order to produce devices more reliable with a more natural appearance. First introduced in 1973 by Scott et al., inflatable prosthesis provides now high general satisfaction rates (69-94%), better than in malleable prostheses, except for few authors.\n\nIn addition to changes in materials and construction, the two main manufacturers of IPP, Boston scientific AMS (Marlborough, MA, USA) and Coloplast (Minneapolis, MN, USA), modernized the pump mechanism of their devices. Since the introduction of AMS IPP, three main pump formats have been used : the standard pump has been replaced in 2004 by the \" Tactile \" pump and then the \" Momentary Squeeze \" (MS) pump in 2006, smaller and easier to deflate by not requiring the patient to hold the deflation button throughout deflation. Coloplast also replaced in 2008 their \" Genesis \" pump by a \" One Touch Release \" (OTR) pump, and finally in 2014 by the current \" Touch \" pump, smaller, and presenting a biconcave deflation button, easier to find.\n\nDespite all technological advances, appropriate pre-operative counselling and careful post-operative teachning, a significant part of patients has still difficulties to handle the pump and thus, does not use their IPP, regardless of any material malfunction. That situation obviously leads to patient's dissatisfaction and highlights the operating risks of a useless surgical procedure.\n\nThe purposes of this study were:to identify the risks factors, modifiable and non-modifiable, for patients' difficulty to inflate and\u002For deflate their device after IPP implantation, then to show a correlation between easy handling and post-operative satisfaction. And last but not least, to show an association between pre-operative pump pattern viewing and handling and post-operative easy handling. That information could help the physicians to improve the pre-operative selection of patients and to adapt the peri-operative care in order to improve patients satisfaction.",[24,25,26],"Surgery","Satisfaction","Penile Prosthesis; Complications","RECRUITING","2026-06-25",{"date":30,"type":31},"2026-06-29","ACTUAL",{"date":33,"type":31},"2014-01-24",{"date":35,"type":20},"2027-06-25",{"name":37,"class":38},"Centre Hospitalier Universitaire de Nice","OTHER",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":48,"minAge":17,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":59,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":66,"leadSponsor":68,"locationsCount":39},"100641446","use-of-hand-extension-rubber-during-intravenous-catheter-placement-100641446","NCT07659015","Use of Hand Extension Rubber During Intravenous Catheter Placement","The Effect of Hand Extension Rubber Used in Patients With Peripheral Intravenous Catheter Insertion on Pain, Anxiety and Satisfaction: A Randomized Controlled Trial","PIC","Inclusion Criteria:\n\n* Volunteers willing to participate in the study\n* Patients aged 18-65\n* Patients who are alert and able to communicate verbally in Turkish\n* Patients assigned to the green zone during triage\n* Patients suitable for PICC placement in the left cephalic and basilic veins\n* Patients who are right-handed\n* Patients with a VAS pain score of 0 prior to the PIC procedure\n\nExclusion Criteria:\n\n* Patients with acute or chronic pain\n* Patients with conditions that cause limited mobility, such as muscle disorders or grip dysfunction\n* Patients with peripheral neuropathy, arteriovenous fistula, or bilateral mastectomy\n* Patients with a psychiatric diagnosis (as self-reported)\n* Patients with communication impairments (hearing, speech, and vision)\n* Patients with a history of negative PIC procedure experiences\n\nTerminating Criteria:\n\n* Participants wishing to withdraw from the study at any stage after giving their consent\n* Failure of the PIC procedure\n* Failure to use the hand extension band until the end of the procedure\n* Occurrence of complications related to the PIC procedure during the procedure","ALL","65 Years",{"count":51,"type":20},114,"INTERVENTIONAL",[54],"NA","The study aims to investigate the effect of a hand extension rubber used in patients with peripheral intravenous catheters on pain, anxiety, and satisfaction.",[57,58,25],"Pain","Anxiety",[60,61,46,57,58,25],"Nursing","Peripheral intravenous catheter","2026-06-15",{"date":64,"type":31},"2026-06-22",{"date":62,"type":20},{"date":67,"type":20},"2026-08-01",{"name":69,"class":38},"Necmettin Erbakan University",{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":48,"minAge":17,"maxAge":4,"enrollmentInfo":78,"targetDuration":4,"studyType":52,"phases":80,"briefSummary":81,"conditions":82,"keywords":84,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":100},"100610493","supporting-families-in-the-icu-100610493","NCT07228299","Supporting Families in the ICU","Supporting Families in the ICU: The Chaplain Family Project Multicenter RCT","SF-ICU","We will enroll patient\u002Fsurrogate dyads.\n\nPatients will be eligible if:\n\n* They are age 18 or older at the time of screening.\n* They are judged to lack decisional capacity based on either:\n\na Glasgow Coma Scale (GCS) score of 8 or less; or a GCS of 9-13 with at least one secondary criterion (intubation, sedation, delirium, or noted by clinicians to be unresponsive, comatose or unable to follow commands).\n\n\\* They have an eligible surrogate willing to participate.\n\nSurrogates will be eligible if:\n\n* They are age 18 or older,\n* They are considered the legally authorized representative (LAR) based on prior appointment by the patient or each state's medical consent law.\n\nPatient\u002Fsurrogate dyads will be ineligible if:\n\n\\* They are unable to complete enrollment activities within 96 hours of admission to the ICU.\n\nPatients will be ineligible if:\n\n* They are being discharged from the ICU within 24 hours.\n* They are intubated for surgery but expected to be extubated soon (typically within 24 hours).\n* They are imminently dying or have a planned terminal wean.\n\nSurrogates will be ineligible if:\n\n\\*They are unable to complete study procedures in English.",{"count":79,"type":20},64,[54],"The overarching goal of our work is to test the effect of high-quality spiritual care for ICU family surrogates on outcomes of psychological and spiritual well-being and medical decision making. Our team has developed an approach to high quality spiritual care intervention for ICU surrogates, called the Spiritual Care Assessment and Intervention (SCAI) framework, which is delivered by a chaplain interventionist to ICU surrogates.",[58,83,25],"Well-Being",[85,86,87,88,89],"spirituality","religion","surrogate decision making","proxy decision making","chaplain","NOT_YET_RECRUITING","2026-05-04",{"date":93,"type":31},"2026-05-06",{"date":95,"type":20},"2026-06-01",{"date":97,"type":20},"2026-08-31",{"name":99,"class":38},"Indiana University",2,{"id":102,"slug":103,"hasResults":11,"nctId":104,"briefTitle":105,"officialTitle":106,"acronym":107,"eligibilityCriteria":108,"healthyVolunteers":11,"sex":109,"minAge":17,"maxAge":4,"enrollmentInfo":110,"targetDuration":4,"studyType":52,"phases":112,"briefSummary":113,"conditions":114,"keywords":120,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":126,"lastUpdatePostDateStruct":127,"startDateStruct":128,"completionDateStruct":129,"leadSponsor":131,"locationsCount":100},"100615087","virtual-reality-as-a-method-for-pain-and-anxiety-control-during-first-trimester-procedural-abortion-100615087","NCT07288047","Virtual Reality as a Method for Pain and Anxiety Control During First Trimester Procedural Abortion","Virtual Reality as an Adjunctive Agent for the Management of Pain and Anxiety During First Trimester Procedural Abortion: a Randomized Controlled Trial","CALM-VR","Inclusion Criteria:\n\n* Patients at Planned Parenthood of Western Pennsylvania who have decided to undergo and are eligible for a procedural abortion.\n* 18 years old or older\n* \\\u003C14 weeks gestation on day of abortion\n* Able to comprehend written English\n* Willing to comply with the study protocol\n* Willing and able to provide informed consent\n\nExclusion Criteria:\n\n* History of vertigo\n* History of epilepsy\n* Claustrophobia\n* Significant hearing or visual impairments (such as deafness or blindness)\n* Require hearing aids\n* Have an implanted medical device, such as cardiac pacemaker or defibrillator\n* Require misoprostol for cervical preparation\n* Prior unsuccessful attempt at abortion during this pregnancy","FEMALE",{"count":111,"type":20},72,[54],"The goal of this clinical trial is to learn whether use of a virtual reality (VR) headset showing a meditative nature video will help reduce pain and anxiety during a first trimester procedural abortion. Investigators will enroll 72 patients undergoing a first trimester procedural abortion with usual care to manage pain and anxiety compared to use of a VR headset in addition to usual care to see if use of the VR headset will decrease pain and anxiety and increase satisfaction with the procedure.",[115,116,117,25,118,119],"Abortion, First Trimester","Pain Management","Pain After Surgery","Satisfaction With Care","Anxiety After Surgery",[121,122,123,124,125],"satisfaction","virtual reality","procedural abortion","pain control","anxiety control","2026-05-01",{"date":93,"type":31},{"date":126,"type":31},{"date":130,"type":20},"2026-10-30",{"name":132,"class":38},"Study Investigator",{"id":134,"slug":135,"hasResults":11,"nctId":136,"briefTitle":137,"officialTitle":138,"acronym":139,"eligibilityCriteria":140,"healthyVolunteers":11,"sex":109,"minAge":17,"maxAge":4,"enrollmentInfo":141,"targetDuration":4,"studyType":52,"phases":143,"briefSummary":144,"conditions":145,"keywords":149,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":161,"completionDateStruct":163,"leadSponsor":165,"locationsCount":39},"100634631","pre-anesthetic-teleconsultations-during-pregnancy-100634631","NCT07542197","Pre-anesthetic Teleconsultations During Pregnancy","ECO-CAM: Pre-anesthetic Consultations During Pregnancy: Benefits of Teleconsultation for Patient Assessment, Information, and Ecological Impact","ECO-CAM","Inclusion Criteria:\n\n* Pregnant patients scheduled to give birth at the Bordeaux University Hospital, ASA score 1 or 2, for their primary pregnancy, who have booked an anesthesia appointment on one of the half-days when teleconsultation is available in the department\n* Have access to the internet and functional computer equipment (smartphone, computer)\n* Have a valid email address and telephone number\n\nExclusion Criteria:\n\n* Minor patient (under 18 years old at the time of inclusion)\n* Individuals not affiliated with or beneficiaries of a social security scheme\n* Patients who do not speak French\n* Persons under legal guardianship\n* Psychiatric conditions that impair the ability to consent to or participate in the study\n* Severe spinal pathology (scoliosis requiring a brace or surgery, ankylosing spondylitis), history of spinal surgery\n* Comorbidities with ASA score ≥3",{"count":142,"type":20},250,[54],"Quality of teleconsultation in comparison to face-to-face consultation for pre anesthetic evaluation in pregnant persons before delivery will be evaluated. Quality is evaluated with a composite criterion comprising 7 elements required for security of anesthesia. Discordance between this composite criterion during the pre anesthesia visit the day of delivery and pre anesthesia consultation several weeks before delivery will be assessed.",[146,147,25,148],"Pregnancy","Anesthesia","Telemedicine",[150,151,152,153,154,155,156,157],"pre anesthetic consultation","anesthesia","obstetrics","carbon footprint","e-health","electronic medical records","telehealth","telemedicine","2026-04-22",{"date":160,"type":31},"2026-04-28",{"date":162,"type":20},"2026-06-30",{"date":164,"type":20},"2028-06",{"name":166,"class":38},"University Hospital, Bordeaux",{"id":168,"slug":169,"hasResults":11,"nctId":170,"briefTitle":171,"officialTitle":172,"acronym":4,"eligibilityCriteria":173,"healthyVolunteers":11,"sex":48,"minAge":17,"maxAge":4,"enrollmentInfo":174,"targetDuration":4,"studyType":52,"phases":176,"briefSummary":177,"conditions":178,"keywords":182,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":185,"lastUpdatePostDateStruct":186,"startDateStruct":187,"completionDateStruct":189,"leadSponsor":191,"locationsCount":4},"100631105","integration-of-a-robotic-platform-for-clinical-monitoring-of-patients-with-severe-acquired-brain-injury-in-high-intensity-care-units-100631105","NCT07496346","Integration of a Robotic Platform for Clinical Monitoring of Patients With Severe Acquired Brain Injury in High-Intensity Care Units","A Pilot Study on the Integration of the Rob-In Care Robotic Platform in High-Intensity Care Units for Monitoring Patients With Severe Acquired Brain Injury","Inclusion Criteria:\n\n* Admission to the Neurorehabilitation Unit\n* Requirement for clinical monitoring and\u002For sub-intensive care\n* Ability to provide informed consent, or availability of a legally authorized representative to provide consent\n\nExclusion Criteria:\n\n* No indication for intensive or sub-intensive clinical monitoring\n* Expected hospitalization duration insufficient to complete the study protocol\n* Participation in another clinical study that may interfere with the present study",{"count":175,"type":20},12,[54],"Frailty is not related exclusively to age, but represents a state of increased biological and clinical vulnerability characterized by reduced functional reserve and greater susceptibility to adverse events, even in response to minor stress factors. In patients with complex conditions, such as severe acquired brain injuries, early detection and prompt treatment of clinical deterioration are essential to reduce the risk of acute readmission, complications, and in-hospital mortality. Many of these events are potentially predictable and preventable, given the presence of appropriate monitoring systems.\n\nAdvanced care models, including early warning systems, have been developed to support healthcare professionals in identifying patients at risk by detecting significant changes in physiological parameters. In recent years, technological innovations-particularly in the fields of robotics and telemedicine-have created new opportunities to enhance clinical monitoring, enabling continuous data collection and more timely, proactive interventions.\n\nSocial assistive robots are emerging as promising tools in healthcare settings. These systems can support clinicians and nurses in routine monitoring activities, help reduce workload, and facilitate more efficient and personalized care. By integrating robotic assistance with digital health platforms, it is possible to improve the quality and responsiveness of patient management, especially in high-complexity environments such as neurorehabilitation units.\n\nThis study focuses on the use of an innovative robotic telemedicine system based on the integration of the MOVER-L prototype with the ROB.IN.CARE platform, promoted by Item Oxygen (Bari, Italy). The system is designed to continuously monitor patients' clinical conditions, collecting vital parameters and identifying early signs of deterioration. It supports healthcare professionals by providing real-time data and alerts, enabling earlier and more targeted interventions.\n\nThe study is a low-intensity interventional clinical trial conducted in a Neurorehabilitation Unit. Patients with varying levels of clinical severity, classified according to the Glasgow Coma Scale, are enrolled and divided into two groups: a control group receiving standard care and an experimental group monitored using the robotic system in addition to usual care.\n\nThe primary objective of the study is to evaluate the feasibility, usability, safety, and reliability of this robotic telemedicine solution in a real clinical setting. In addition, the study assesses its acceptability among both patients and healthcare professionals. These aspects are measured using validated tools, including the System Usability Scale (SUS) and the Health and Safety Executive Stress Scale (HSE), to understand the impact of the technology on user experience and workload.\n\nThe integrated MOVER-L\u002FROB.IN.CARE system combines robotic assistance with continuous monitoring of vital signs and advanced software architecture. The platform incorporates predictive algorithms designed to stratify clinical risk and assess patient severity. It utilizes established clinical scoring systems, such as the Modified Early Warning Score (MEWS) for early detection of clinical deterioration, the quick Sequential Organ Failure Assessment (qSOFA) for sepsis risk evaluation, and the Kidney Disease: Improving Global Outcomes (KDIGO) criteria for the assessment of acute kidney injury.\n\nBy enabling early identification of clinical worsening, the system aims to improve the timeliness and effectiveness of healthcare interventions, optimize clinical workflow, and reduce the risk of adverse events and complications. Ultimately, this study explores whether robotic telemedicine can represent a safe, feasible, and valuable tool to enhance the management of fragile patients in neurorehabilitation settings.",[179,180,181,25],"User Experience","Usability","Acceptability",[183,184],"Robotic platform","Monitoring system","2026-04-17",{"date":158,"type":31},{"date":188,"type":20},"2026-05",{"date":190,"type":20},"2026-11",{"name":192,"class":38},"Ernesto Losavio",{"id":194,"slug":195,"hasResults":11,"nctId":196,"briefTitle":197,"officialTitle":198,"acronym":199,"eligibilityCriteria":200,"healthyVolunteers":201,"sex":109,"minAge":17,"maxAge":4,"enrollmentInfo":202,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":204,"conditions":205,"keywords":209,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":216,"lastUpdatePostDateStruct":217,"startDateStruct":219,"completionDateStruct":221,"leadSponsor":223,"locationsCount":39},"100465830","an-analysis-of-adverse-events-and-satisfaction-outcomes-of-women-who-underwent-primary-and-secondary-breast-augmentation-using-silimed-breast-implants-with-smooth-surface-100465830","NCT05345821","An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants With Smooth Surface","Post-market Monitoring and Control of Safety and Efficacy of Silimed® Breast Implants With Smooth Surface (STEPS S)","STEPS S","Inclusion Criteria:\n\n* Provide written informed consent\n* Female at birth\n* Be 18 years of age or older\n* Have a complaint of hypomastia\n* Have an indication for breast augmentation with silicone implants\n* Ability to comply with the protocol throughout the follow-up period.\n\nExclusion Criteria:\n\n* Replacement of breast implants due to a complication\n* Breast reconstruction in at least one breast\n* Informed pregnancy or breastfeeding at the time of inclusion\n* Sequelae of mastopexy\n* Ptosis requiring mastopexy\n* Breast changes or lumps rated BI-RADS 3 or higher on preoperative ultrasound or mammograms\n* Advanced fibrocystic disease at the time of implantation\n* Neoplasia of any type not yet treated or undergoing treatment at the time of implantation, - Active infection not yet treated or undergoing treatment at any site at the time of implantation\n* Report or record of adverse reactions or intolerance to silicone prior to implantation\n* Report or record of immune diseases affecting the active or undergoing treatment (e.g. lupus erythematosus, discoid lupus, scleroderma, etc.) at the time of implantation\n* Signs of inflammation of the breast or implant site at the time of implantation\n* Increased risk of post-implantation complications -immediate surgical complications caused by illicit drug use or medication use\n* Having participated in another clinical trial within 6 months prior to implant placement\n* Any other condition which, based on the opinion of the investigator or designee, may prevent the provision of informed consent, make study participation unsafe, compromise protocol adherence, complicate the interpretation of study outcome data, or otherwise interfere with the achievement of study objectives",true,{"count":203,"type":20},384,"The study investigates the safety and performance of Silimed® brand smooth surface breast implants in women born with indication for primary and secondary (revision) augmentation to be followed up for 10 years. The safety of the smooth-surfaced Silimed® implant will be evaluated by estimating known and unexpected short-term and long-term risk\u002Fadverse event rates through patient reports of adverse events after implantation. The performance of using Silimed® brand smooth surface breast implants will be evaluated by evaluating satisfaction and quality of life after implantation.",[206,207,25,208],"Breast Implant; Complications","Quality of Life","Safety and Performance",[210,121,211,212,213,214,215],"Breast Implant","qualify of life","smooth surface","post-market","safety","efficacy","2026-03-12",{"date":218,"type":31},"2026-03-16",{"date":220,"type":31},"2022-10-05",{"date":222,"type":20},"2036-08",{"name":224,"class":225},"Silimed Industria de Implantes Ltda","INDUSTRY",{"id":227,"slug":228,"hasResults":11,"nctId":229,"briefTitle":230,"officialTitle":231,"acronym":232,"eligibilityCriteria":233,"healthyVolunteers":201,"sex":109,"minAge":17,"maxAge":4,"enrollmentInfo":234,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":236,"conditions":237,"keywords":238,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":216,"lastUpdatePostDateStruct":245,"startDateStruct":246,"completionDateStruct":248,"leadSponsor":250,"locationsCount":39},"100313106","an-analysis-of-adverse-events-and-satisfaction-outcomes-of-women-who-underwent-primary-and-secondary-breast-augmentation-using-silimed-breast-implants-100313106","NCT03356132","An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants","Post-market Monitoring and Control of Safety and Efficacy of Silimed® Breast Implants With Textured Surface and Polyurethane Foam-coated Surface","STEPS A","Inclusion Criteria:\n\n* provide written informed consent.\n* female at birth\n* be 18 years of age or older\n* have received breast implant(s) for indication of primary or secondary augmentation until 21 days before (including the visit window)\n* having received a breast implant with a textured surface or a breast implant with a surface coated with Silimed® polyurethane foam\n* ability to comply with the protocol throughout the follow-up period.\n\nExclusion Criteria:\n\n* mammary reconstruction in at least one breast or augmentation after previous reconstruction,\n* pregnancy informed or breastfeeding at the inclusion moment,\n* advanced fibrocystic disease at the time of implantation,\n* neoplasia of any type not yet treated or being treated at the time of implantation, infection in activity not yet treated or being treated at any site at the time of implantation,\n* reporting or recording of adverse reactions or intolerance to polyurethane or silicone prior to implantation,\n* immune diseases affecting active connective tissue or (eg, lupus erythematosus, discoid lupus, scleroderma, etc.) at the time of implantation,\n* signs of inflammation of the breast or implant site at the time of implantation,\n* Increased risk of immediate postoperative complications due to use of illicit drugs or medications,\n* Increased risk of immediate post-surgical complications caused by illicit drug use or medication use,\n* have participated in another clinical study up to 6 months prior to the placement of the implant,\n* any other condition which, based on the opinion of the investigator or designee, may prevent the provision of informed consent, renders participation in the study is unsafe, compromises adherence to the protocol, complicates the interpretation of data from the study outcome, or otherwise interferes with the achievement of study objectives.",{"count":235,"type":20},632,"The study investigates the safety and performance of Silimed® silicone gel breast implants with a textured surface and Silimed® silicone gel breast implants with polyurethane coated surface. Female patients who underwent primary or secondary breast augmentation using Silimed® breast implants will be followed-up through 10 years. The safety of each type of Silimed® breast implant is going to be assessed by estimating the known and unexpected short- and long-term risk \u002F adverse event rates. The performance of each type of Silimed® breast implant is going to be assesses by estimating the satisfaction and quality of life after implantation.",[206,207,25],[239,240,121,241,242,243,244],"breast implant","complication","quality of life","augmentation","textured","polyurethane",{"date":218,"type":31},{"date":247,"type":31},"2018-07-31",{"date":249,"type":20},"2036-12",{"name":224,"class":225},{"id":252,"slug":253,"hasResults":11,"nctId":254,"briefTitle":255,"officialTitle":255,"acronym":4,"eligibilityCriteria":256,"healthyVolunteers":201,"sex":48,"minAge":257,"maxAge":258,"enrollmentInfo":259,"targetDuration":4,"studyType":52,"phases":261,"briefSummary":262,"conditions":263,"keywords":268,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":270,"lastUpdatePostDateStruct":271,"startDateStruct":273,"completionDateStruct":275,"leadSponsor":277,"locationsCount":39},"100621924","the-effect-of-virtual-reality-distraction-on-pain-and-discomfort-associated-with-bitewing-radiographs-in-pediatric-patients-100621924","NCT07376941","The Effect of Virtual Reality Distraction on Pain and Discomfort Associated With Bitewing Radiographs in Pediatric Patients","Inclusion Criteria:\n\n1. Healthy\n2. Cooperative children\n3. Aged 4 to 12 years\n4. Referred to the radiology department for two-bitewing radiographs.\n\nExclusion Criteria:\n\n1- Children with a history of epilepsy or anxiety disorder","4 Years","12 Years",{"count":260,"type":20},90,[54],"This study will be conducted at King Abdulaziz University Dental Hospital (KAUDH). Ethical approval was obtained from the Research Ethics Committee of the Faculty of Dentistry at King Abdulaziz University (32-03-25).\n\nInclusion criteria will include healthy and cooperative children aged 4 to 12 years who are referred to the radiology department for two-bitewing radiographs. Children with a history of epilepsy or anxiety disorder will be excluded. The study's purpose, risks, benefits, and limitations will be explained to the parents or guardians of eligible children by trained dental interns. Those who agree to participate will be asked to sign an Arabic consent form before their involvement. Additionally, an assent form will be obtained from children aged seven and older.\n\nSubjects' age, gender, previous dental experience, and behavior during previous dental visits, as assessed by Frankl's behavior rating scale , will be recorded, along with whether they own or have prior exposure to a virtual reality device. Only children with cooperative and definitely cooperative behavior will be included.\n\nA randomization sequence with an allocation ratio of 1:1 will be generated using computer software and kept with a radiology assistant who is not involved in the study to ensure allocation concealment. Due to the nature of the study, neither the subject nor the radiologist will be blinded to the group allocation. However, the statistician will be blinded to which group each subject will be allocated.\n\nBefore taking the radiographs, subjects will be asked to select a video from a list of popular cartoon shows or a video of their preference. In the test group, the subjects will wear virtual reality device goggles (LG 360 virtual reality \\[VR\\] headset, LG Electronics) connected to a mobile phone, and the chosen video will be played. In the control group, radiographs will be taken without the use of any distraction device. The sounds of the videos will be played on headphones. All bitewing radiographs will be taken by the same radiologist, following the As Low As Reasonably Achievable (ALARA) protocol and hospital guidelines. The procedure uses either size one or size two bitewing Photostimulable Phosphor digital sensors, along with a film holder and a rectangular collimator. While taking the radiographs, the Tell-Show-Do behavior management technique will be used with all participating children, and they will be recorded with a high-resolution camera.\n\nThe camera will aim toward the face and the body. Later, two trained and calibrated evaluators will independently assess the participating children's behavioral pain using the face, legs, activity, cry, and consolability (FLACC) behavioral pain assessment scale. The FLACC scale ranges from 0 to 10, with 0 indicating no pain and 10 the worst possible pain. Additionally, the behavior during the BWS will also be recorded using Frankl's behavior rating scale classification. Training and calibration for the evaluators will involve watching videos of 20 randomly selected children during their dental treatment. A stopwatch will be used to measure the chair time required to take the radiographs. In the test group, the time needed to place the VR device will be included.\n\nImmediately after taking the BWS, the subjects will be shown the Arabic version of the Wong-Baker FACES pain rating scale. They will be asked to select the face that best describes their feelings during the procedure. Finally, the satisfaction with the use of VR during BWS taking will be assessed using a five-point Likert scale, where zero indicates 'not satisfied at all' and 10 means' very satisfied'. Subjects who require repeating any of the BWS will be excluded from the study",[264,265,266,25,267],"Objective Pain and Discomfort","Subjective Pain and Discomfort","Behavior","Future Preferences",[269],"Satisfaction, Virtual Reality, Bitewings Radiographs","2026-01-26",{"date":272,"type":31},"2026-01-29",{"date":274,"type":20},"2026-02-01",{"date":276,"type":20},"2026-05-30",{"name":278,"class":38},"King Abdulaziz University",{"id":280,"slug":281,"hasResults":11,"nctId":282,"briefTitle":283,"officialTitle":284,"acronym":4,"eligibilityCriteria":285,"healthyVolunteers":11,"sex":48,"minAge":286,"maxAge":287,"enrollmentInfo":288,"targetDuration":290,"studyType":21,"phases":4,"briefSummary":291,"conditions":292,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":297,"lastUpdatePostDateStruct":298,"startDateStruct":299,"completionDateStruct":301,"leadSponsor":303,"locationsCount":39},"100620344","associations-of-cranial-outcomes-and-parental-expectations-and-satisfaction-100620344","NCT07356401","Associations of Cranial Outcomes and Parental Expectations and Satisfaction","Association Between Cranial Morphological Changes, Parental Expectations, and Satisfaction Following Cranial Remolding Orthosis Treatment in Infants","Inclusion Criteria:\n\n* Infants diagnosed with positional cranial deformities (e.g., plagiocephaly, brachycephaly, or asymmetrical cranial shape)\n* Infants who received cranial remolding orthosis treatment\n* Use of a custom-made cranial remolding orthosis\n* Availability of pre-treatment and post-treatment cranial measurements\n* Parents or legal guardians who provided informed consent and were able to complete expectation and satisfaction questionnaires\n* Infants who completed the planned cranial remolding orthosis treatment and follow-up period\n\nExclusion Criteria:\n\n* Infants with neurological disorders, genetic syndromes, or congenital conditions affecting cranial growth\n* Infants who underwent previous cranial surgery or other cranial interventions\n* Infants who received non-custom-made or prefabricated cranial orthoses\n* Incomplete clinical records or missing pre- or post-treatment cranial measurements\n* Parents or caregivers unable to complete the questionnaires due to language or cognitive limitations\n* Infants with a diagnosis of microcephaly or macrocéphaly.","3 Months","18 Months",{"count":289,"type":20},20,"1 Month","This study aims to investigate the association between objective cranial morphological changes and parental expectations and satisfaction in infants undergoing treatment with a cranial remolding orthosis (CRO). Infants diagnosed with positional cranial deformities and prescribed CRO treatment will be included. Cranial morphological outcomes will be assessed using standardized cranial measurements obtained before and after the treatment period.\n\nParental treatment expectations will be evaluated prior to the initiation of CRO therapy using the Treatment Expectation Questionnaire (TR.TEX-Q), while parental satisfaction with the device and treatment process will be assessed at the end of treatment using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST).\n\nThe primary objective of the study is to examine the relationships between changes in cranial morphology and parental expectations and satisfaction scores. Secondary objectives include exploring the association between baseline expectations and post-treatment satisfaction. The findings are expected to provide insight into how objective treatment outcomes align with family-reported perceptions in cranial remolding orthosis therapy.",[293,294,295,296,25],"Plagiocephaly","Cranial Defect","Orthosis","Expectancy","2026-01-22",{"date":270,"type":31},{"date":300,"type":31},"2025-11-25",{"date":302,"type":20},"2026-03-15",{"name":304,"class":38},"Gulhane School of Medicine",{"id":306,"slug":307,"hasResults":11,"nctId":308,"briefTitle":309,"officialTitle":309,"acronym":310,"eligibilityCriteria":311,"healthyVolunteers":11,"sex":48,"minAge":17,"maxAge":4,"enrollmentInfo":312,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":314,"conditions":315,"keywords":325,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":328,"lastUpdatePostDateStruct":329,"startDateStruct":331,"completionDateStruct":333,"leadSponsor":335,"locationsCount":337},"100617117","procedural-sedation-and-analgesia-for-treatment-of-adults-with-fractures-and-dislocations-in-the-emergency-department-100617117","NCT07314450","Procedural Sedation and Analgesia for Treatment of Adults With Fractures and Dislocations in the Emergency Department","PAINEX","Inclusion Criteria:\n\n1. Age ≥18.\n2. Patients with the following injuries are eligible:\n\n   1. Reduction treatment of shoulder dislocation\n   2. Reduction treatment of elbow dislocation\n   3. Reduction treatment of distal radius fractures, application of cast\n   4. Reduction treatment of finger fractures\u002Fdislocation\n   5. Casting treatment of upper extremity fractures\n\n      * Proximal humerus fracture, application of fixed sling\n      * Humeral shaft fracture, application of Sarmiento brace\n      * Supracondylar fracture, application of angled cast\n   6. Reduction treatment of hip dislocation\n   7. Reduction treatment of patella dislocation\n   8. Reduction of tibial shaft fracture, application of cast\n   9. Reduction treatment of ankle fractures including distal tibia fracture\n   10. Reduction treatment for toe fractures\u002Fdislocation\n   11. Casting treatment of lower extremity fractures\n\n       * Distal femur fracture, application of cast\u002Ftraction\n       * Proximal tibia fracture, application of cast or hinged brace\n       * Ankle fracture, application of walker\n\nExclusion Criteria:\n\n1. Unable to give informed consent (e.g. unconscious, psychotic or dementia)\n2. Unwilling to participate in the study\n3. Prior inclusion in the study\n4. Already included in another clinical study at the same day\u002Fhospital visit\n5. Pregnant or breastfeeding",{"count":313,"type":20},200,"The goal of this observational study is to evaluate the effectiveness and safety of different procedural sedation and analgesia methods used for adults with painful fractures requiring reduction treatment in the emergency department.\n\nThe main questions it aims to answer are:\n\n* Which sedation and analgesia methods provide the best patient satisfaction and pain relief?\n* How do different treatment methods affect clinician satisfaction and the occurrence of adverse events?\n\nThe investigators will compare different types of procedural sedative and analgesic treatments (such as systemic sedation\u002Fanalgesia and regional techniques like nerve or hematoma blocks) to see which approach offers the best patient satisfaction and most effective pain control.\n\nParticipants will:\n\nBe adult patients with upper or lower extremity fractures or joint dislocations requiring painful reduction procedures.\n\nReceive one of the routinely used sedation or analgesia treatments (or no analgesia) during their emergency department care.\n\nReport their pain levels and satisfaction before, during, and after treatment. Be monitored for any side effects, complications, or use of antidotes. Data will be collected over a six-month period at Odense University Hospital, Holbæk Hospital, and Zealand University Hospital, Køge, following the STROBE guidelines for observational studies.",[316,317,318,319,320,25,321,322,323,324],"Pain, Procedural","Analgesia","Extremity Injury","Patient Satisfaction","Satisfaction, Personal","Upper Extremity Injury","Lower Extremity Fracture","Upper Extremity Fracture","Extremity Injuries Lower",[326,327],"Emergency Department","Procedural sedation and analgesia","2025-12-17",{"date":330,"type":31},"2026-01-02",{"date":332,"type":31},"2025-07-29",{"date":334,"type":20},"2026-07-01",{"name":336,"class":38},"Region Zealand",3,{"id":339,"slug":340,"hasResults":11,"nctId":341,"briefTitle":342,"officialTitle":342,"acronym":4,"eligibilityCriteria":343,"healthyVolunteers":11,"sex":48,"minAge":17,"maxAge":4,"enrollmentInfo":344,"targetDuration":4,"studyType":52,"phases":346,"briefSummary":347,"conditions":348,"keywords":349,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":353,"lastUpdatePostDateStruct":354,"startDateStruct":356,"completionDateStruct":358,"leadSponsor":360,"locationsCount":39},"100597261","impact-of-verbal-compared-to-structured-information-on-patients-anxiety-and-satisfaction-undergoing-uroflowmetry-100597261","NCT07056192","Impact of Verbal Compared to Structured Information on Patient's Anxiety and Satisfaction Undergoing Uroflowmetry","Inclusion Criteria:\n\n1. Age 18 years and above\n2. Undergoing uroflowmetry for the first time\n3. Patients, who can hear, read and comprehend the education in either Urdu or English language.\n\nExclusion Criteria:\n\n1. Language barrier\n2. Known psychiatric illness\n3. Unable to comprehend instructions due to any neurological issue\n4. Unable to void adequate volume even after 3 attempts",{"count":345,"type":20},132,[54],"Background: Uroflowmetry (UFM) is a non-invasive initial, simple, and widely performed first-line investigation for the evaluation of lower urinary tract symptoms. Despite its non-invasive nature, uroflowmetry can provoke anxiety and affect satisfaction, often due to misunderstandings about the procedure.\n\nObjective: This randomized control trial aimed to compare the effects of structured versus verbal education on anxiety and satisfaction in patients undergoing uroflowmetry.\n\nMethodology: A single-blind, parallel-arm study will include 48 patients, which will be randomized into structured (brochure) and verbal counseling groups. The modified Amsterdam Preoperative Anxiety and Information Scale (APAIS-M) will assess anxiety, while satisfaction will be measured by using a questionnaire adapted from Dogun et al. Descriptive statistics, Chi-square, and independent t-tests will be employed for data analysis in spss 23.",[58,25],[350,58,351,352,25],"Uroflowmetry","Verbal education","Structured information","2025-07-09",{"date":355,"type":31},"2025-07-11",{"date":357,"type":31},"2025-01-01",{"date":359,"type":20},"2025-07-15",{"name":361,"class":38},"Aga Khan University Hospital, Pakistan",{"id":363,"slug":364,"hasResults":11,"nctId":365,"briefTitle":366,"officialTitle":366,"acronym":367,"eligibilityCriteria":368,"healthyVolunteers":11,"sex":48,"minAge":17,"maxAge":4,"enrollmentInfo":369,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":371,"conditions":372,"keywords":374,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":379,"lastUpdatePostDateStruct":380,"startDateStruct":382,"completionDateStruct":383,"leadSponsor":384,"locationsCount":39},"100595867","nutrition-in-action-service-learning-project-100595867","NCT07038031","Nutrition in Action: Service-Learning Project","NA_SL","Inclusion Criteria:\n\n* University students enrolled in the Food Education Strategies subject of the Nutrition and Dietetics Degree at the UVic-UCC.\n\nExclusion Criteria:\n\n* Online students.\n* Students who do not voluntarily agree to participate in the study",{"count":370,"type":20},65,"Service-learning methodology (SL) combines training and community processes in a single project where participants are trained while working on real needs of the environment with the aim of improving it. This methodology enhances the professional skills of the students, their personal and competence development, and develops a deeper sense of civic responsibility.\n\nThe Human Nutrition and Dietetics Degree (ND) of the Faculty of Health and Welfare Sciences (FCSB) of the University of Vic-Central University of Catalonia decided to incorporate this methodology, according to University's training model, with the aim of generating learning situations that allow them to act, reflect and solve problems based on significant learning. We applied SL in the subject of Food Education Strategies designing and implementing a small food education program with 1 contact to detect the needs of the users, and 3 educational sessions. The implementation of the SL is based on the SL guide proposed by the Service Learning Network of Catalan Universities and we make it with 4 local social entities.\n\nThe teacher responsible for the SL is coordinated with responsibles from entities who act as facilitators, authorizing the collection of data from the people of the entities, recruiting, informing and collecting the willingness to participate from the users.\n\nWe plan to study the experience of participating in the SL activity in terms of student acquisition of skills and satisfaction of all the parties involved, based on an observational study carried out during 4 academic years (2025-2029).\n\nThrough convenience sampling, a participation of 65 people is expected (20 students, 40 users, 5 responsible from entities).\n\nData collection plans to compile information on: a.Experience of the SL of the university student body. b. Assessments of the users and responsibles from entities on the impact, quality and satisfaction with the SL activity. c. Proposal for improving the SL activity with the entities using the rubric for self-assessment and improvement of SL projects.\n\nData collection will take place at the end of the activity using the REDCap platform (Research Electronic Data Capture) and the statistic analysis is planned using the SPSS statistical program.",[373,25],"Skills Acquisition",[375,376,377,378],"Service-learning","Skills","Food habits","Higher education","2025-06-25",{"date":381,"type":31},"2025-06-26",{"date":274,"type":20},{"date":162,"type":20},{"name":385,"class":38},"University of Vic - Central University of Catalonia",{"id":387,"slug":388,"hasResults":11,"nctId":389,"briefTitle":390,"officialTitle":391,"acronym":4,"eligibilityCriteria":392,"healthyVolunteers":11,"sex":48,"minAge":17,"maxAge":49,"enrollmentInfo":393,"targetDuration":4,"studyType":52,"phases":395,"briefSummary":396,"conditions":397,"keywords":4,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":398,"lastUpdatePostDateStruct":399,"startDateStruct":401,"completionDateStruct":403,"leadSponsor":405,"locationsCount":4},"100588908","effects-of-shotblocker-and-manual-pressure-on-pain-and-satisfaction-100588908","NCT06947525","Effects of Shotblocker and Manual Pressure on Pain and Satisfaction","Effects of Shotblocker and Manual Pressure on Pain and Satisfaction During Peripheral Venous Catheter Placement: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Admission to the urology clinic,\n* No verbal, perceptual and visual communication problems,\n* Between the ages of 18 and 65,\n* Literate,\n* Volunteer to participate in the study,\n* Not using medication that will create a chronic analgesic effect,\n* Not having chronic or acute pain,\n* No intervention has been performed on the vein where the PIC is placed in the last month,\n* No scar tissue or infection in the areas where the PIC will be placed,\n* Not having a disease that will cause problems in feeling pain (such as neuropathy)\n\nExclusion Criteria:\n\n* The individual wants to leave the study,\n* Feels unwell during the PIC placement (such as dizziness, palpitations),\n* Uses sedatives or alcohol,",{"count":394,"type":20},81,[54],"This study aims to determine the effects of shotblocker and manual pressure applied during peripheral venous catheter placement on pain and satisfaction. 81 patients hospitalized in the Urology clinic will be included in the study. Patients will be assigned to three groups as shotblocker (n=27), manual pressure (n=27) and control group (n=27) by block randomization method.\n\nResearch Hypotheses\n\n* H1-1: The mean pain scores of the intervention group to which shotblocker was applied during peripheral intravenous catheterization are different from the control group.\n* H1-2: The mean pain scores of the intervention group to which manual pressure was applied during peripheral intravenous catheterization are different from the control group.\n* H1-3: The mean satisfaction scores of the intervention group to which shotblocker was applied during peripheral intravenous catheterization are different from the control group.\n* H1-4: The mean satisfaction scores of the intervention group to which manual pressure was applied during peripheral intravenous catheterization are different from the control group.",[57,25],"2025-04-20",{"date":400,"type":31},"2025-04-27",{"date":402,"type":20},"2025-04-28",{"date":404,"type":20},"2025-06-30",{"name":69,"class":38},{"id":407,"slug":408,"hasResults":11,"nctId":409,"briefTitle":410,"officialTitle":411,"acronym":4,"eligibilityCriteria":412,"healthyVolunteers":201,"sex":109,"minAge":17,"maxAge":413,"enrollmentInfo":414,"targetDuration":4,"studyType":52,"phases":416,"briefSummary":417,"conditions":418,"keywords":420,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":423,"lastUpdatePostDateStruct":424,"startDateStruct":426,"completionDateStruct":428,"leadSponsor":430,"locationsCount":39},"100587372","effects-of-pilates-ball-and-sacral-massage-applications-on-labor-pain-labor-duration-and-childbirth-satisfaction-100587372","NCT06927531","Effects of Pilates Ball and Sacral Massage Applications on Labor Pain, Labor Duration and Childbirth Satisfaction","Effects of Pilates Ball and Sacral Massage Applications on Labor Pain, Labor Duration and Childbirth Satisfaction: A Randomized Controlled Study","Inclusion Criteria:\n\n* Pregnant women over 18 years old and under 35 years old\n* Term pregnancies (38-41 weeks gestation)\n* Primiparous\n* Those with a single live fetus\n* Vertex development\n* Those who do not have any risk factors during pregnancy (Dermatological disease, Preeclampsia, active membrane rupture, oligohydramnios and polyhydramnios, gestational diabetes, placental anomalies, intrauterine growth retardation, intrauterine dead fetus, macrosomic babies, fetal distress, etc.)\n* Those who do not have any obstacles for Pilates ball application\n* Those who do not have any chronic diseases (Hypertension, DM, ...)\n* Those in the active phase of labor, those who have at least 1 hour of labor follow-up\n* Pregnant women who voluntarily accept to participate in the study\n\nExclusion Criteria:\n\n* Indications for Caesarean section (such as presentation disorder, breech presentation)\n* Those who underwent induction\n* Those whose labor duration was shorter than 1 hour or longer than 8 hours\n* Those who underwent vacuum forceps or shoulder insertion","35 Years",{"count":415,"type":20},105,[54],"As researchers, we believe that Pilates ball and manual sacral massage applications can be easily and cost-free applied in maternity clinics in our country. For all these reasons, this study was planned as a randomized controlled study to evaluate the effects of Pilates ball and sacral massage applications in labor on labor pain, labor duration, and labor satisfaction.\n\nThe research will be carried out between December 1, 2024 and May 1, 2025 in two public hospitals affiliated with the Gaziantep Provincial Health Directorate. The sample of the research will consist of 35 pregnant women in the Pilates ball group, 35 in the sacral massage group and 35 in the control group, totaling 105 pregnant women who meet the criteria for inclusion in the research. Applications to the intervention groups will be made during the active phase of labor. Personal Information Form, Labor Monitoring Form, Application Monitoring Form to record the number and duration of applications, Visual Analog Scale to assess labor pain, Partograph to assess labor duration and Labor Satisfaction Scale to assess maternal satisfaction will be used in data collection. Data will be analyzed with tests appropriate to normal distribution characteristics in the SPSS 24 package program. At the end of the research, the effects of Pilates ball and sacral massage applications in labor on labor pain, labor duration and labor satisfaction will be evaluated.",[419,25],"Labor Pain",[421,422],"sacral massage","pilates ball","2025-04-14",{"date":425,"type":31},"2025-04-15",{"date":427,"type":31},"2025-02-20",{"date":429,"type":20},"2025-12-30",{"name":431,"class":38},"Ege University",{"id":433,"slug":434,"hasResults":11,"nctId":435,"briefTitle":436,"officialTitle":437,"acronym":4,"eligibilityCriteria":438,"healthyVolunteers":11,"sex":48,"minAge":439,"maxAge":440,"enrollmentInfo":441,"targetDuration":4,"studyType":52,"phases":443,"briefSummary":444,"conditions":445,"keywords":447,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":451,"lastUpdatePostDateStruct":452,"startDateStruct":454,"completionDateStruct":456,"leadSponsor":458,"locationsCount":39},"100477262","effectiveness-of-multisensoral-nature-based-intervention-in-hospitalized-children-during-venous-blood-sampling-100477262","NCT05494684","Effectiveness of Multisensoral Nature-based Intervention in Hospitalized Children During Venous Blood Sampling","Effectiveness of Multisensoral Nature-based Intervention in Hospitalized Children Aged 5 to 9 Years During Venous Blood Sampling: A Randomized Controlled Trial","Inclusion Criteria:\n\n1. The child is aged between 5 and 9 years old\n2. The child has a long-term illness (such as diabetes or rheumatism)\n3. The child has previous experience of venous blood sampling\n4. The child's level of development is age-appropriate (such as, the child is cared for at home or in day care\u002Fday nursery or attends school in the same level as the other children)\n5. Child and parent understand and speak the Finnish language\n\nExclusion Criteria:\n\n1. The child has a diagnosis of abnormal neurological development (such as, a child has difficulty understanding spoken language or expressing emotions)\n2. The child has chronic pain that has lasted more than 3 months and requires strong painkillers (opiates).\n3. The child undergoes an examination or treatment during a check-up at the outpatient clinic that requires medical treatment similar to anesthesia\n4. The child is taking a sedative medication.","5 Years","9 Years",{"count":442,"type":20},53,[54],"This randomized controlled trial (RCT) study aims to evaluate the effectiveness of multisensoral nature-based intervention compare to standard care in relieving anxiety, fear and pain in hospitalized child aged 5 to 9 years and parent's anxiety and satisfaction during venous blood sampling. The assessment uses different measures to assess child's anxiety, fear, pain and parent's anxiety and satisfaction during venous blood sampling.",[58,446,57,25],"Fear",[448,449,450],"Children","Nature-based Intervention","Venipuncture","2025-03-31",{"date":453,"type":31},"2025-04-04",{"date":455,"type":20},"2025-08-01",{"date":457,"type":20},"2026-12-31",{"name":459,"class":38},"University of Oulu",{"id":461,"slug":462,"hasResults":11,"nctId":463,"briefTitle":464,"officialTitle":465,"acronym":4,"eligibilityCriteria":466,"healthyVolunteers":201,"sex":48,"minAge":467,"maxAge":467,"enrollmentInfo":468,"targetDuration":4,"studyType":52,"phases":470,"briefSummary":471,"conditions":472,"keywords":473,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":480,"lastUpdatePostDateStruct":481,"startDateStruct":483,"completionDateStruct":485,"leadSponsor":487,"locationsCount":39},"100584897","effects-of-virtual-reality-and-helfer-skin-tap-during-vaccination-100584897","NCT06895330","Effects of Virtual Reality and Helfer Skin Tap During Vaccination","Virtual Reality Vs. Helfer Skin Tap: Which One is Helping Children Cope with Fear, Anxiety, and Pain During Vaccination?","Inclusion Criteria:\n\n* 13 years\n* being conscious (with the ability to communicate)\n\nExclusion Criteria:\n\n* having a physical and psychological condition\n* taking any analgesics, sedatives, or anticonvulsants in the past 24 hours\n* having chronic or life-threatening disease\n* refusing the virtual reality or helfer skin tap technique intervention during vaccine injection.","13 Years",{"count":469,"type":20},138,[54],"The aim of this study was to detect and compare the effects of Virtual Reality and Helfer Skin Tap methods on pain, fear, anxiety, and satisfaction during the administration of Tetanus-Diphtheria vaccine to school-aged children. This study was an experimental randomized controlled trial. The sample was included 138 children in a family health centers aged 13 years who underwent Tetanus-Diphtheria vaccine. The participants were randomly assigned to Virtual Reality, Helfer Skin Tap, and control groups. Each group included 46 children, of whom 23 were female and 23 were male. The State-Trait Anxiety Inventory, Children's Fear Scale and Visual Analog Scale were used to collect the data.",[116,446,58,25],[474,475,476,477,122,478,479],"pain","fear","anxiety","satistaction","helfer skin tap","vaccine","2025-03-19",{"date":482,"type":31},"2025-03-26",{"date":484,"type":20},"2025-05-03",{"date":486,"type":20},"2026-04-15",{"name":488,"class":38},"Mehmet Akif Ersoy University",{"id":490,"slug":491,"hasResults":11,"nctId":492,"briefTitle":493,"officialTitle":494,"acronym":4,"eligibilityCriteria":495,"healthyVolunteers":11,"sex":109,"minAge":4,"maxAge":496,"enrollmentInfo":497,"targetDuration":4,"studyType":52,"phases":499,"briefSummary":500,"conditions":501,"keywords":503,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":505,"lastUpdatePostDateStruct":506,"startDateStruct":508,"completionDateStruct":510,"leadSponsor":512,"locationsCount":39},"100575375","post-c-section-pain-control-satisfaction-with-erector-spinae-simple-block-vs-lateral-quadratus-lumborum-block-100575375","NCT06771466","Post-c-section Pain Control Satisfaction with Erector Spinae Simple Block Vs Lateral Quadratus Lumborum Block","Patients' Satisfaction for Pain Control Modalities After Caesarean Section Using Erector Spinae Plain Block Vs Lateral Quadratus Lumborum Block. a Randomized Clinical Trial","Inclusion Criteria:\n\n* Parturient female\n* Scheduled for elective cesarean section\n\nExclusion Criteria:\n\n* Known allergy to any of the medications used\n* Patients refused to participate in the study\n* Patients with emergency section,\n* Patients with Bleeding disease\n* Patients with postpartum haemorrhage","40 Years",{"count":498,"type":20},126,[54],"The study will compare the difference between the patient's satisfaction after Erector spinae plane block (ESP) and Quadratus Lumborum block lateral approach after caesarean section alone or as part of multimodal analgesia.\n\nThe primary outcome is to test whether the type of plane block has an implication on the patients' satisfaction.\n\nThe secondary outcome is to test the difference between the two approaches on the hospital discharge",[25,502],"Pain Management After Surgery",[504],"nerve block, pain, opioids, patient satisfaction, cesarean section","2025-01-10",{"date":507,"type":31},"2025-01-13",{"date":509,"type":20},"2025-03",{"date":511,"type":20},"2025-10",{"name":513,"class":38},"Wael Sayed El Gharabawy",{"id":515,"slug":516,"hasResults":11,"nctId":517,"briefTitle":518,"officialTitle":519,"acronym":4,"eligibilityCriteria":520,"healthyVolunteers":11,"sex":109,"minAge":17,"maxAge":521,"enrollmentInfo":522,"targetDuration":4,"studyType":52,"phases":524,"briefSummary":525,"conditions":526,"keywords":532,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":536,"lastUpdatePostDateStruct":537,"startDateStruct":539,"completionDateStruct":541,"leadSponsor":543,"locationsCount":4},"100572471","the-use-of-virtual-reality-technology-during-oocyte-retrieval-for-in-vitro-fertilization-100572471","NCT06733701","The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization","The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization: a Randomized Controlled Pilot Study","Inclusion Criteria:\n\n\\- All adults undergoing their first oocyte retrieval\n\nExclusion Criteria:\n\n* severe visual impairment\n* contraindications to using VR technology according to manufacturer specifications including:\n* severe motion sickness\n* epilepsy\u002Fprevious seizure\n* claustrophobia\n* current migraine\n* heart disease\n* use of medical devices such as cardiac pacemaker or hearing aids","43 Years",{"count":523,"type":20},50,[54],"Ultrasound-guided oocyte retrieval (OR) is a short, but oftentimes painful procedure, during which the follicles are punctured trans-vaginally to obtain oocytes for in vitro fertilization (IVF). Conscious sedation is the most commonly used method of pain relief, yet several studies have shown that more than half of women report moderate to high levels of pain and up to 7% of women report extreme or unacceptable levels of pain during OR. Adjuvant virtual reality (VR) therapy has been explored to reduce psychological stress during dental procedures, burn wound care, colonoscopy, as well as other minor procedures. Hence, the purpose of this study is to evaluate the use of VR technology during IVF treatment, particularly with respect to tolerability, patient satisfaction, and pain reduction during oocyte retrieval.",[527,528,529,530,25,531],"Oocyte Retrieval","Adverse Events","Procedural Anxiety","Pain Intensity","Medication Administration",[533,527,534,535],"Virtual Reality","In Vitro Fertilization","Randomized Control Trial","2024-12-13",{"date":538,"type":31},"2024-12-18",{"date":540,"type":20},"2025-01-15",{"date":542,"type":20},"2025-12-31",{"name":544,"class":38},"Mount Sinai Hospital, Canada",{"id":546,"slug":547,"hasResults":11,"nctId":548,"briefTitle":549,"officialTitle":550,"acronym":4,"eligibilityCriteria":551,"healthyVolunteers":201,"sex":48,"minAge":552,"maxAge":553,"enrollmentInfo":554,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":556,"conditions":557,"keywords":559,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":564,"lastUpdatePostDateStruct":565,"startDateStruct":567,"completionDateStruct":569,"leadSponsor":571,"locationsCount":573},"100409244","pediatric-perioperative-satisfaction-questionnaire-100409244","NCT04608968","Pediatric Perioperative Satisfaction Questionnaire","Development and Validation of a Perioperative Satisfaction Questionnaire in Children Population","Inclusion criteria:\n\n* children 7 years and older\n* elective surgery\n* general anesthesia\n* abiliy to understand and read questions\n\nExclusion criteria:\n\n* emergency\n* cognitive trouble\n* intellectual disability","7 Years","17 Years",{"count":555,"type":20},600,"The aim of this study is to develop and validate a self-report questionnaire to evalutate the satisfaction of the children after surgery.",[558,448,25],"Perioperative",[560,561,448,562,563],"Validity","Questionnaire","health quality of life","Self report","2024-11-25",{"date":566,"type":31},"2024-11-27",{"date":568,"type":31},"2020-09-01",{"date":570,"type":20},"2026-12-01",{"name":572,"class":38},"University Hospital, Montpellier",6,{"id":575,"slug":576,"hasResults":11,"nctId":577,"briefTitle":578,"officialTitle":579,"acronym":4,"eligibilityCriteria":580,"healthyVolunteers":201,"sex":109,"minAge":17,"maxAge":4,"enrollmentInfo":581,"targetDuration":4,"studyType":52,"phases":582,"briefSummary":583,"conditions":584,"keywords":4,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":585,"lastUpdatePostDateStruct":586,"startDateStruct":588,"completionDateStruct":590,"leadSponsor":592,"locationsCount":39},"100534673","anxiety-pain-and-satisfaction-related-to-first-vaginal-examination-in-women-100534673","NCT06241885","Anxiety, Pain, and Satisfaction Related to First Vaginal Examination in Women","The Effect of Gynaecological Drape and Specially Developed Gynaecological Shorts on Anxiety, Pain, and Satisfaction Related to First Vaginal Examination in Women: a Randomised Controlled Study","Inclusion Criteria:\n\n* Literate,\n* 18 years of age or older,\n* Can speak and understand Turkish,\n* You are a woman who is having a vaginal examination for the first time\n* Women who volunteered to participate in the study\n\nExclusion Criteria:\n\n* Physical or mental illness that prevents them from communicating,\n* Vaginal examination by a health professional other than the designated gynaecologist,\n* Those who answered the research questions incompletely and\n* Women who want to withdraw from the study",{"count":19,"type":20},[54],"The Effect of Gynaecological Drape and Specially Developed Gynaecological Shorts on Anxiety, Pain and Satisfaction Related to First Vaginal Examination in Women: A Randomised Controlled Study",[58,57,25],"2024-09-23",{"date":587,"type":31},"2024-09-25",{"date":589,"type":20},"2024-11-15",{"date":591,"type":20},"2025-06-15",{"name":593,"class":38},"Kahramanmaras Sutcu Imam University",{"id":595,"slug":596,"hasResults":11,"nctId":597,"briefTitle":598,"officialTitle":599,"acronym":600,"eligibilityCriteria":601,"healthyVolunteers":11,"sex":109,"minAge":17,"maxAge":4,"enrollmentInfo":602,"targetDuration":439,"studyType":21,"phases":4,"briefSummary":604,"conditions":605,"keywords":608,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":610,"lastUpdatePostDateStruct":611,"startDateStruct":613,"completionDateStruct":615,"leadSponsor":617,"locationsCount":39},"100333021","pessary-satisfaction-criteria-for-urogenital-prolapse-100333021","NCT03615872","Pessary Satisfaction Criteria for Urogenital Prolapse","Evaluation of Patient Satisfaction With Pessary in the Treatment of Genital Prolapse","PeSaCUP","Inclusion Criteria:\n\n* The research protocol will be proposed to all patients with a symptomatic genital prolapse, over 18 years of age, who speak French and who agree to participate in this study\n* Prolapse defined according to the International Classification POP-Q-.\n\nExclusion Criteria:\n\n* Minors under 18 years of age\n* Pregnant or lactating women\n* Women Not speaking French (the good understanding of French is necessary to answer questionnaires and for informed information)\n* Women unable to understand due to cognitive impairment or degenerative disease (dementia\u002F Alzheimer's disease)",{"count":603,"type":20},150,"Genital prolapse is a common pathology with a prevalence ranging from 2.9 to 11.4% or 31.8% to 97.7%, depending on whether a questionnaire or clinical examination is used. The use of pessary in the treatment of prolapse remains discussed despite a satisfaction rate of 50 to 80% in the literature and a minimal complications rate.\n\nThe main objective of this study is to assess the satisfaction of patients carrying a pessary in the first year after the laying.",[606,607,25],"Genital Prolapse","Pessary",[241,609],"efficiency","2024-09-19",{"date":612,"type":31},"2024-09-20",{"date":614,"type":31},"2018-06-20",{"date":616,"type":20},"2025-06",{"name":618,"class":38},"University Hospital, Caen",{"id":620,"slug":621,"hasResults":11,"nctId":622,"briefTitle":623,"officialTitle":623,"acronym":4,"eligibilityCriteria":624,"healthyVolunteers":11,"sex":48,"minAge":17,"maxAge":4,"enrollmentInfo":625,"targetDuration":4,"studyType":52,"phases":627,"briefSummary":628,"conditions":629,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":633,"lastUpdatePostDateStruct":634,"startDateStruct":636,"completionDateStruct":638,"leadSponsor":640,"locationsCount":100},"100559889","evaluating-a-water-quality-assurance-fund-intervention-in-ghana-and-kenya-100559889","NCT06570005","Evaluating a Water Quality Assurance Fund Intervention in Ghana and Kenya","Eligibility to receive the intervention was determined by water system criteria:\n\nInclusion Criteria:\n\n* The district or county government was interested in participating in the Assurance Fund program and water systems within the district\u002Fcounty were accessible to a partner central laboratory that was able to provide water sample collection and testing services for a fee.\n* Water systems were functional.\n* Water systems were piped water systems (Kenya, Ghana) or mechanized boreholes with a single tapstand (Ghana).\n* Water systems could afford regular water quality testing from the selected laboratory.\n\nExclusion Criteria:\n\n* Water systems did not meet above inclusion criteria.\n\nTo be eligible to participate in household surveys, participants need to be at least 18 years of age and a customer of a eligible water system.",{"count":626,"type":20},4800,[54],"The objective of this study is to evaluate the effects of a novel financial and capacity strengthening intervention (the 'Water Quality Assurance Fund' program) on water safety management in rural Ghana and Kenya. The investigators hypothesize the intervention will improve water system operator knowledge, chlorination practices, and water quality at the point of collection, as well as improve consumer satisfaction, awareness, and willingness-to-pay for water that is tested and treated.",[630,631,632,25],"Water Quality","Water Treatment","Knowledge","2024-08-22",{"date":635,"type":31},"2024-08-26",{"date":637,"type":31},"2022-12-06",{"date":639,"type":20},"2025-09-30",{"name":641,"class":38},"The Aquaya Institute"]